Compare XRAY & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XRAY | HTGC |
|---|---|---|
| Founded | 1899 | 2003 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2008 | N/A |
| Metric | XRAY | HTGC |
|---|---|---|
| Price | $11.70 | $15.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $14.58 | ★ $18.86 |
| AVG Volume (30 Days) | ★ 3.0M | 1.9M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | 5.43% | ★ 12.01% |
| EPS Growth | ★ 33.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | $2.06 | $5.24 |
| P/E Ratio | ★ N/A | $8.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $13.70 |
| 52 Week High | $17.18 | $19.67 |
| Indicator | XRAY | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 57.73 |
| Support Level | $10.96 | $13.77 |
| Resistance Level | $12.28 | $16.08 |
| Average True Range (ATR) | 0.44 | 0.34 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 13.91 | 71.48 |
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.